51. 全身性強皮症 Scleroderma Clinical trials / Disease details

臨床試験数 : 523 / 薬物数 : 608 - (DrugBank : 156) / 標的遺伝子数 : 114 - 標的パスウェイ数 : 215

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02370784 (ClinicalTrials.gov)	February 2015	26/1/2015	Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma	The Effect of Atorvastatinon Microvascular Endothelial Function and Raynaud in Early Diffuse Systemi ...	Scleroderma	Drug: atorvastatin;Drug: Placebo	Robyn T. Domsic, MD, MPH	National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)	Completed	18 Years	70 Years	All	24	Phase 2	United States
2	EUCTR2005-003775-21-GB (EUCTR)	14/08/2008	10/11/2005	Effects of atorvastatinon microcirculatory endothelial function in patients with systemic sclerosis ...	Effects of atorvastatinon microcirculatory endothelial function in patients with systemic sclerosis ...	Systemic sclerosis (also termed 'scleroderma')	Trade Name: Lipitor Product Name: Lipitor	Salford Royal Hospitals NHS Trust	University of Manchester	Not Recruiting			Female: yes Male: yes	36	Human pharmacology (Phase 1): no Therapeutic exploratory (Phase 2): no Therapeutic confirmatory - (P ...	United Kingdom

First Previous1Next Last